- ViewRay ( NASDAQ: VRAY ) said the SUNY Upstate Cancer Center in Syracuse, New York selected its MRIdian MRI-Guided Radiation Therapy System.
- The center will be the first in Upstate New York to offer the precision of MRIdian's advanced MRI-guided radiation therapy to patients with pancreas, prostate, lung, liver, breast, and oligometastatic cancers, the company said in an Oct. 6 press release.
- ViewRay noted that to date, over 25K patients have been treated with MRIdian and currently, 54 MRIdian systems are installed at hospitals around the world.
For further details see:
ViewRay MRI-guided radiation therapy selected by SUNY upstate cancer center